- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Johnson & Johnson Ratings Report.
Johnson & Johnson reported fourth quarter financial results, missing on earnings, but beating on revenue.
Stocks hold higher on Tuesday as earnings winners DuPont and Alibaba lead gains in industrials and technology names.
CEO Alex Gorsky dishes a bit on Monday's meeting with President Trump during Johnson & Johnson's conference call.
Jim Cramer thought Johnson & Johnson's results were decent but he remains cautious on pharma.